Specialized Medical Company (TADAWUL:4019)

TADAWUL:4019 Cash Flow Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	151.07	185.22	168.7	102.96	55.97
Depreciation & Amortization	90.45	87.48	87.76	103.94	102.94
Loss (Gain) From Sale of Assets	2.32	2.29	0.02	-0.06	-0.05
Provision & Write-off of Bad Debts	16.33	9.68	6.21	36.13	51.32
Other Operating Activities	46.69	48.05	56.65	34.69	23.28
Change in Accounts Receivable	91.14	92.16	-89.05	-121.1	-111.96
Change in Inventory	-5.72	3.19	-5.89	-0.79	4.56
Change in Accounts Payable	4.41	-10.99	4.68	14.87	-32.13
Change in Other Net Operating Assets	-17.88	-33.3	4.3	6.85	-178.17
Operating Cash Flow	378.8	383.78	233.37	177.48	-84.25
Operating Cash Flow Growth	62.32%	64.45%	31.49%	-	-
Capital Expenditures	-90.28	-94.27	-72.84	-60.89	-75.14
Sale of Property, Plant & Equipment	0.91	0.93	0.84	0.06	0.2
Investing Cash Flow	-89.37	-93.34	-72	-60.82	-74.94
Short-Term Debt Issued	-	75.54	20	15	170
Long-Term Debt Issued	-	-	-	-	47.71
Total Debt Issued	96.76	75.54	20	15	217.71
Long-Term Debt Repaid	-	-85.51	-53.44	-46.96	-25.84
Net Debt Issued (Repaid)	-65	-9.98	-33.44	-31.96	191.88
Common Dividends Paid	-125	-200	-60	-50	-35
Other Financing Activities	65.11	-35.81	-41.88	-25.73	-16.34
Financing Cash Flow	-124.9	-245.78	-135.33	-107.69	140.54
Net Cash Flow	164.53	44.66	26.04	8.97	-18.65
Free Cash Flow	288.52	289.52	160.53	116.6	-159.38
Free Cash Flow Growth	79.73%	80.35%	37.68%	-	-
Free Cash Flow Margin	19.64%	20.11%	11.73%	9.65%	-15.13%
Free Cash Flow Per Share	1.15	1.16	1.89	1.37	-1.88
Cash Interest Paid	34.89	35.81	41.88	25.73	16.34
Levered Free Cash Flow	-	172.76	41.2	251.67	-
Unlevered Free Cash Flow	-	200.87	71.48	270.31	-
Change in Working Capital	71.95	51.06	-85.97	-100.17	-317.69

Source: S&P Global Market Intelligence. Standard template. Financial Sources.